Dizziness and the Otolaryngology Point of View
S Sorathia, Y Agrawal, MC Schubert - Medical Clinics, 2018
… Benign paroxysmal positional vertigo, 16. Labyrinthitis, 9. Meniere disease,
5 … Common peripheral vestibular diseases include benign paroxysmal
positional vertigo (BPPV), Meniere disease, and vestibular neuritis …
5 … Common peripheral vestibular diseases include benign paroxysmal
positional vertigo (BPPV), Meniere disease, and vestibular neuritis …
 |  |  |
[PDF] Are There Any Systemic Effects of the Intratympanic Administration of Dexamethasone?
E ŞENTÜRK, S TUĞRUL, YS YILDIRIM, R DOĞAN… - 2018
… Examples of immune-mediated inner ear diseases include post-meningitis labyrinthitis,
Cogan syndrome, idiopathic sudden hearing loss, Meniere's disease, and progressive
sensory-neural hearing loss (5) … in 1991 for the treatment of Meniere's disease (15) …
Cogan syndrome, idiopathic sudden hearing loss, Meniere's disease, and progressive
sensory-neural hearing loss (5) … in 1991 for the treatment of Meniere's disease (15) …
| | |
The LURN research network neuroimaging and sensory testing (NIST) study: Design, protocols, and operations
HH Lai, B Naliboff, AB Liu, CL Amundsen, JS Shimony… - Contemporary Clinical Trials, 2018
… Contraindications to QST testing Participants cannot: • Currently, habitually,
or had previously (within 12 months) used artificial nails, nail enhancements,
or nail extensions that cover any portion of the thumbnail, and/or • Have …
or had previously (within 12 months) used artificial nails, nail enhancements,
or nail extensions that cover any portion of the thumbnail, and/or • Have …
| | |
[PDF] SENSORINEURAL HEARING LOSS IN CHRONIC MIDDLE EAR CLEFT DISEASE: A PREVALENCE STUDY FROM SOUTH INDIA
R Dham, R Sampathkumar, S Gnanatilakan - INTERNATIONAL JOURNAL OF …, 2018
… untreated unilateral CSOM where the other ear was clinically and audiologically
normal. Exclusion criteria: Cases of pediatric age group, Presbycusis, Ototoxicity,
Meniere's disease, SNHL and complications of CSOM. Informed …
normal. Exclusion criteria: Cases of pediatric age group, Presbycusis, Ototoxicity,
Meniere's disease, SNHL and complications of CSOM. Informed …
| | |
[PDF] 60. The sound of silence
M Dey, M Bukhari - Rheumatology Advances in Practice, 2018
… Atypical CS also includes vestibulo-auditory symptoms, occurring within
two years of initial presentation and inconsistent with a Meniere's-like
phenomenon. Approximately 70% of such patients have vasculitis with …
two years of initial presentation and inconsistent with a Meniere's-like
phenomenon. Approximately 70% of such patients have vasculitis with …
| | |
COMPOSITIONS AND METHODS FOR MODULATING TOLL LIKE RECEPTOR SIGNAL
EM Medof, J Liu, MG Strainic - US Patent App. 15/974,307, 2018
… idiopathic thrombocytopenic purpura, iga nephropathy, inflammatory
demyelinating polyneuopathy, interstitial cystitis, irritable bowel syndrome
(ibs), Kawasaki's disease, lichen planus, Lou Gehrig's disease, lupoid hepatitis …
demyelinating polyneuopathy, interstitial cystitis, irritable bowel syndrome
(ibs), Kawasaki's disease, lichen planus, Lou Gehrig's disease, lupoid hepatitis …
| | |
[PDF] Two-Dimensional Video Analysis of the Effects of Theraband® CLX Neuromuscular Exercises on the Overhead Deep Squat
B Hoogenboom, A Stinson, A Huyser, M Suter - Journal of Performance Health …, 2018
… before the study. Those with a disorder that affected balance, such as a history of vertigo
from Meniere's disease, a neurological disease, or peripheral neuropa- thy related
to diabetes, were also excluded. Volunteers were excluded …
from Meniere's disease, a neurological disease, or peripheral neuropa- thy related
to diabetes, were also excluded. Volunteers were excluded …
| | |
Chronic Ear Disease
SD Emmett, J Kokesh, D Kaylie - Medical Clinics, 2018
Skip to Main Content …
| | |
Cysteine/Glutathione Deficiency: A Significant and Treatable Corollary of Disease
P Ghezzi, KV Lemley, JP Andrus, SC De Rosa… - The Therapeutic Use of N …, 2019
Glutathione (GSH) deficiency may play a pivotal role in a variety of
apparently unrelated clinical conditions and diseases. Orally administered
N-acetylcysteine (NAC), which replenishes the cysteine...
apparently unrelated clinical conditions and diseases. Orally administered
N-acetylcysteine (NAC), which replenishes the cysteine...
| | |
Nanoparticle Compositions and Methods Thereof to Restore Vascular Integrity
JM Friedman, M Navati, AJ Friedman, P Cabrales - US Patent App. 15/534,389, 2018
The present invention relates to methods for treating systemic inflammation.
In certain embodiments, the method comprises administering a therapeutically
effective amount of curcumin-selenium loaded n.
In certain embodiments, the method comprises administering a therapeutically
effective amount of curcumin-selenium loaded n.
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου